These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6348681)

  • 1. Transfusion therapy with platelets and leukocytes.
    Luban NL
    Pediatr Ann; 1983 Jun; 12(6):437-44. PubMed ID: 6348681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Refractory effect and alloimmunization after transfusion of thrombocytes].
    Volkova RI; Agranenko VA
    Gematol Transfuziol; 1992 Feb; 37(2):16-21. PubMed ID: 1426903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloimmunization by leukocyte-rich or leukocyte-poor random single donor platelets.
    Gmür J; Burger J; Sauter C; Oelz O; Frick PG
    Prog Clin Biol Res; 1990; 337():45-8. PubMed ID: 2191337
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonfatal graft-versus-host disease occurring after transfusion with leukocytes and platelets obtained from normal donors.
    Cohen D; Weinstein H; Mihm M; Yankee R
    Blood; 1979 Jun; 53(6):1053-7. PubMed ID: 36181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection.
    Hecht T; Wolf JL; Mraz L; Scott EP; Patz LD
    JAMA; 1982 Nov; 248(18):2301-3. PubMed ID: 6752444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological support of component blood transfusion therapy].
    Shablin VN; Serova LD; Abdulkadyrov KM; Mel'nikova VN
    Probl Gematol Pereliv Krovi; 1978 Aug; 23(8):3-7. PubMed ID: 683985
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive value of enzyme-linked immunoassay platelet crossmatching for transfusion of platelet concentrates to alloimmunized recipients.
    Brubaker DB; Duke JC; Romine M
    Am J Hematol; 1987 Apr; 24(4):375-87. PubMed ID: 3551590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic effects of leukocytes present in transfused cellular blood products.
    Bordin JO; Heddle NM; Blajchman MA
    Blood; 1994 Sep; 84(6):1703-21. PubMed ID: 8080981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood component therapy in bone marrow transplantation.
    Brand A; Claas FH; Falkenburg JH; van Rood JJ; Eernisse JG
    Semin Hematol; 1984 Apr; 21(2):141-55. PubMed ID: 6330905
    [No Abstract]   [Full Text] [Related]  

  • 11. [Transfusion of leukocytes and platelets in the treatment of acute leukemia].
    Baklaja R; Stajić M; Banicević B; Jancić M; Cvetković V; Maslovarić S; Susaković N; Andelić M; Stefanović S
    Bilt Hematol Transfuz; 1978; 6(3):31-8. PubMed ID: 295220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of UV radiation in the prevention of human leukocyte antigen alloimmunization.
    Andreu G; Boccaccio C; Klaren J; Lecrubier C; Pirenne F; Garcia I; Baudard M; Devers L; Fournel JJ
    Transfus Med Rev; 1992 Jul; 6(3):212-24. PubMed ID: 1498466
    [No Abstract]   [Full Text] [Related]  

  • 13. Solid phase platelet crossmatching versus complement dependent lymphocytotoxicity--clinical utility.
    Lane D; Shivji S; Turner AR
    Prog Clin Biol Res; 1990; 337():59-62. PubMed ID: 2353019
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet transfusion therapy.
    Slichter SJ
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
    Sniecinski I; O'Donnell MR; Nowicki B; Hill LR
    Blood; 1988 May; 71(5):1402-7. PubMed ID: 3282572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet crossmatching with Capture P: clinical relevance.
    Böck M; Heim MU; Schleich I; Weindler R; Wagner M; Mempel W
    Infusionstherapie; 1989 Aug; 16(4):183-5. PubMed ID: 2807565
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncology Grand Rounds. Platelet transfusion--clinical applications in the oncology setting.
    Daly PA
    Am J Med Sci; 1980; 280(3):130-42. PubMed ID: 7457494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
    Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
    Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.